`Sent:
`
`ratna lingamanenilcambridge/biogen;nsf;ratna.lingamaneni@biogenidec.com;smtp
`Tue Dec 27 2005 15:31: II EST
`
`Page I of2
`
`To:
`
`CC:
`
`MoodStamp:
`Subject:
`
`Nonnal
`Re: BG12 MS IND- Cross ftmctional review- Comments due by TOMORROW
`
`Please note that your comments on BG12 MS IND Module 2 are due tomonow, Dec 28th.
`Thank you
`-Ratna
`
`Ratna Lingamaneni/Cambridge/Biogen
`12/19/2005 03:03PM
`Message Size: 2617.8 KB
`
`To
`
`BG 12 MS IND -Cross frmctional review- Comments due by Dec 28
`
`http://rel-web/Relativity.Distributed!Download.aspx? ArtifactiD= 1168211&GUID=f0626... 11112/2015
`
`Page 1 of 2
`
`Biogen Exhibit 2322
`Coalition v. Biogen
`IPR2015-01993
`
`
`
`Page 2 of 2
`
`Dear all,
`
`Please note that BG12 IND for MS indication has been sent to you for review via BRASS workflow.
`The document is also attached below for those who do not have access to BRASS. Your comments are
`due by Dec 28th.
`
`Please let me know if you have any questions or need any referenced study reports for your review.
`
`Thank you
`-Ratna
`
`________________________
`Ratna Lingamaneni, PhD
`Manager, Regulatory Affairs
`Tel: (617) 679-2231
`Fax: (617) 679-3170
`
`http://rel-web/Relativity.Distributed/Download.aspx?ArtifactID=1168211&GUID=f0626...
`
`11/12/2015
`
`Page 2 of 2